ATC code J04 Antimycobacterials is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes...
2 KB (269 words) - 07:31, 31 December 2022
ATC code J01 Antibacterials for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric...
14 KB (1,151 words) - 15:36, 25 January 2024
ATC code J Antiinfectives for systemic use is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed...
542 bytes (185 words) - 22:29, 26 May 2022
ATC code J05 Antivirals for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric...
6 KB (538 words) - 04:59, 18 December 2023
ATC code J06 Immune sera and immunoglobulins is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric...
2 KB (264 words) - 07:33, 31 December 2022
ATC code J02 Antimycotics for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric...
877 bytes (221 words) - 07:30, 31 December 2022
ATC code J07 Vaccines is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed...
8 KB (708 words) - 00:37, 25 September 2024
ATCvet code QJ51 (redirect from ATC code J51)
anatomical group QJ Antiinfectives for systemic use. National issues of the ATC classification may include additional codes not present in this list, which...
5 KB (327 words) - 15:44, 10 November 2021
Susceptibility assay Tuberculin Heaf test Mantoux test Tine test Management (ATC code J04) Isoniazid 4-Aminosalicylic acid Ethambutol Capreomycin Cycloserine Rifampicin...
14 KB (1,385 words) - 04:57, 10 June 2024